The University of Chicago Header Logo

Connection

James Millis to Adult

This is a "connection" page, showing publications James Millis has written about Adult.
Connection Strength

0.615
  1. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.032
  2. Small-for-size donor syndrome? Liver Transpl. 2011 Apr; 17(4):355-6.
    View in: PubMed
    Score: 0.026
  3. Liver hemangioma complicated by obstructive jaundice. Am J Surg. 2008 Sep; 196(3):e3-4.
    View in: PubMed
    Score: 0.021
  4. Giant necrotizing abscess of a liver transplant after gunshot injury. Transplantation. 2007 Nov 27; 84(10):1373-4.
    View in: PubMed
    Score: 0.021
  5. Temporary abdominal coverage for adult liver transplantation. Liver Transpl. 2007 Sep; 13(9):1349-50; author reply 1351-2.
    View in: PubMed
    Score: 0.020
  6. Minocycline toxicity requiring liver transplant. Dig Dis Sci. 2007 Nov; 52(11):3242-4.
    View in: PubMed
    Score: 0.020
  7. Duodenal diverticulum causing xanthogranulomatous pyelonephritis with multiorgan involvement: first case report. Digestion. 2006; 74(3-4):236-7.
    View in: PubMed
    Score: 0.020
  8. Retained colorectal foreign bodies. Dis Colon Rectum. 2006 Aug; 49(8):1240-1; author reply; 1241.
    View in: PubMed
    Score: 0.019
  9. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.019
  10. Combined kidney-pancreas transplant: early abdominal catastrophe in the donor may not be a contraindication. Transplantation. 2006 Apr 27; 81(8):1223.
    View in: PubMed
    Score: 0.018
  11. Advances in adult living donor liver transplantation. Liver Transpl. 2003 Oct; 9(10 Suppl 2):S1.
    View in: PubMed
    Score: 0.015
  12. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation. 2002 Dec 27; 74(12):1735-46.
    View in: PubMed
    Score: 0.015
  13. The impact of donor factors on the outcomes following liver transplantation. Transplant Proc. 2002 Aug; 34(5):1495-6.
    View in: PubMed
    Score: 0.014
  14. Devastating and fatal complications associated with combined vascular and bile duct injuries during cholecystectomy. Arch Surg. 2002 Jun; 137(6):703-8; discussion 708-10.
    View in: PubMed
    Score: 0.014
  15. Efficacy of computed tomography in detecting hepatocellular cancer in adult liver transplant candidates. Transplant Proc. 2001 Feb-Mar; 33(1-2):1854-5.
    View in: PubMed
    Score: 0.013
  16. Bioartificial liver support: report of the longest continuous treatment with human hepatocytes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1935.
    View in: PubMed
    Score: 0.013
  17. Safety of continuous human liver support. Transplant Proc. 2001 Feb-Mar; 33(1-2):1954.
    View in: PubMed
    Score: 0.013
  18. Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
    View in: PubMed
    Score: 0.013
  19. Pancreatic beta cell/islet mass and body mass index. Islets. 2019; 11(1):1-9.
    View in: PubMed
    Score: 0.011
  20. Liver transplantation at the University of Chicago. Clin Transpl. 1999; 231-8.
    View in: PubMed
    Score: 0.011
  21. Validation of a New North American Islet Donor Score for Donor Pancreas Selection and Successful Islet Isolation in a Medium-Volume Islet Transplant Center. Cell Transplant. 2019 02; 28(2):185-194.
    View in: PubMed
    Score: 0.011
  22. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
    View in: PubMed
    Score: 0.011
  23. Complications in 100 living-liver donors. Ann Surg. 1998 Aug; 228(2):214-9.
    View in: PubMed
    Score: 0.011
  24. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant. 2018 04; 18(4):990-997.
    View in: PubMed
    Score: 0.010
  25. Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation. Transplantation. 1997 Feb 15; 63(3):397-403.
    View in: PubMed
    Score: 0.010
  26. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.010
  27. Potential role of Neoral in pediatric liver transplantation. Transplant Proc. 1996 Aug; 28(4):2267-9.
    View in: PubMed
    Score: 0.009
  28. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
    View in: PubMed
    Score: 0.009
  29. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014.
    View in: PubMed
    Score: 0.009
  30. A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation. Cell Transplant. 2016; 25(8):1515-1523.
    View in: PubMed
    Score: 0.009
  31. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transpl Surg. 1995 Jul; 1(4):229-33.
    View in: PubMed
    Score: 0.009
  32. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
    View in: PubMed
    Score: 0.009
  33. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine. 2015 Aug; 49(3):693-702.
    View in: PubMed
    Score: 0.008
  34. Liver transplantation at the University of Chicago. Clin Transpl. 1995; 187-97.
    View in: PubMed
    Score: 0.008
  35. Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One. 2013; 8(6):e67454.
    View in: PubMed
    Score: 0.008
  36. Expanding the envelope: the posterior rectus sheath-liver vascular composite allotransplant. Plast Reconstr Surg. 2013 Feb; 131(2):209e-218e.
    View in: PubMed
    Score: 0.007
  37. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.007
  38. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
    View in: PubMed
    Score: 0.006
  39. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010 Dec; 59(12):1687-93.
    View in: PubMed
    Score: 0.006
  40. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.005
  41. The management of liver transplant recipients treated with cyclosporine. Transplant Proc. 1988 Jun; 20(3 Suppl 3):405-19.
    View in: PubMed
    Score: 0.005
  42. Liver transplantation at UCLA: a report of clinical activities. Clin Transpl. 1988; 29-34.
    View in: PubMed
    Score: 0.005
  43. Hepato-spleno-mesenteric trunk. J Am Coll Surg. 2007 Mar; 204(3):511.
    View in: PubMed
    Score: 0.005
  44. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl. 2004 Oct; 10(10 Suppl 2):A6-22.
    View in: PubMed
    Score: 0.004
  45. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl. 2003 Nov; 9(11):1211-5.
    View in: PubMed
    Score: 0.004
  46. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation. 2001 Sep 27; 72(6):1032-7.
    View in: PubMed
    Score: 0.003
  47. Transplantation of liver grafts from living donors into adults--too much, too soon. N Engl J Med. 2001 May 24; 344(21):1633-7.
    View in: PubMed
    Score: 0.003
  48. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
    View in: PubMed
    Score: 0.003
  49. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
    View in: PubMed
    Score: 0.003
  50. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation. 1999 Nov 15; 68(9):1423-7.
    View in: PubMed
    Score: 0.003
  51. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation. 1999 Jun 27; 67(12):1562-8.
    View in: PubMed
    Score: 0.003
  52. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.003
  53. Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. Transplant Proc. 1998 Jun; 30(4):1249-50.
    View in: PubMed
    Score: 0.003
  54. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
    View in: PubMed
    Score: 0.003
  55. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.003
  56. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.003
  57. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation. 1998 Feb 15; 65(3):393-6.
    View in: PubMed
    Score: 0.003
  58. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation. 1998 Feb 15; 65(3):439-42.
    View in: PubMed
    Score: 0.003
  59. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997 Feb; 24(2):216-21.
    View in: PubMed
    Score: 0.002
  60. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.002
  61. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.002
  62. Small intestine transplantation at the University of California, Los Angeles. Transplant Proc. 1996 Oct; 28(5):2746-7.
    View in: PubMed
    Score: 0.002
  63. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.002
  64. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.002
  65. Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
    View in: PubMed
    Score: 0.002
  66. One thousand liver transplants. The lessons learned. Ann Surg. 1994 May; 219(5):490-7; discussion 498-9.
    View in: PubMed
    Score: 0.002
  67. Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993 Dec; 59(12):806-12.
    View in: PubMed
    Score: 0.002
  68. Celiac compression syndrome and liver transplantation. Ann Surg. 1993 Jul; 218(1):10-2.
    View in: PubMed
    Score: 0.002
  69. Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg. 1992 Sep; 216(3):344-50; discussion 350-2.
    View in: PubMed
    Score: 0.002
  70. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct; 125(10):1261-6; discussion 1266-8.
    View in: PubMed
    Score: 0.002
  71. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
    View in: PubMed
    Score: 0.002
  72. Hepatic artery reconstruction during liver transplantation. Transplantation. 1989 Feb; 47(2):403-6.
    View in: PubMed
    Score: 0.001
  73. Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg. 1989 Jan; 209(1):51-6.
    View in: PubMed
    Score: 0.001
  74. Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy. Transplantation. 1988 Sep; 46(3):479-81.
    View in: PubMed
    Score: 0.001
  75. The quality of survival after liver transplantation. Transplant Proc. 1988 Feb; 20(1 Suppl 1):594-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.